Buddhi Fernando | Biology and Life Sciences | Best Researcher Award

Buddhi Fernando | Biology and Life Sciences | Best Researcher Award

Dr Buddhi Fernando, Department of MLS, Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka

Dr. Buddhi Fernando is a dedicated academic and clinical biochemist from Sri Lanka πŸ‡±πŸ‡°, currently serving as a Lecturer at the Department of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Ruhuna. With a Ph.D. in Clinical Biochemistry from the University of Peradeniya πŸŽ“, Dr. Fernando has pioneered studies on Chronic Kidney Disease of uncertain etiology (CKDu), identifying biomarkers for diagnosis, staging, and risk prediction 🧬🩺. With experience in teaching Clinical Biochemistry, Andrology, Microbiology, and more, she has inspired many students while conducting impactful research. Her award-winning research presentations and global exposure, including a scholarship to Japan 🌏, reflect her academic excellence. Dr. Fernando has co-authored numerous high-impact publications in reputed journals and remains passionate about translational science that directly benefits vulnerable communities. Her persistent pursuit of knowledge, interdisciplinary collaborations, and commitment to public health place her among Sri Lanka’s most promising researchers πŸŒŸπŸ“šπŸ”¬.

Publication Profile

Google ScholarΒ 

Education

Dr. Buddhi Fernando completed her Ph.D. in Clinical Biochemistry πŸ§ͺ at the Faculty of Medicine, University of Peradeniya, Sri Lanka, in 2020. Her dissertation focused on identifying a biomarker profile for CKDu and evaluating its utility in early diagnosis, staging, and risk stratification πŸ§¬πŸ“Š. She earned her B.Sc. in Medical Laboratory Science with a Second-Class Upper Division in 2014 from the Faculty of Allied Health Sciences, University of Peradeniya πŸ₯πŸ”. Her undergraduate research explored the impact of Diabetes Mellitus on heart function in ICR mice 🐭❀️. Earlier, she completed the G.C.E. Advanced Level Examination (2008) and G.C.E. Ordinary Level Examination (2002) with commendable results πŸŽ“πŸ“˜. Dr. Fernando’s academic training merges rigorous scientific methodology with a strong focus on public health relevance, especially in addressing rural disease burdens. Her scholarly foundation has been crucial in supporting her innovative research into CKDu, a condition affecting thousands in Sri Lanka 🩺🌱.

Experience

Dr. Buddhi Fernando has over six years of academic and teaching experience πŸ“š. From November 2019 to date, she has served as a Lecturer (Probationary and then permanent) at the Department of Medical Laboratory Science, University of Ruhuna 🏫. Her teaching responsibilities span Clinical Biochemistry, Microbiology, Andrology, Physiology, and Parasitology 🧫🧠. She has also taken on leadership roles as Batch Coordinator and Unit Coordinator. Previously, she was a Demonstrator at the University of Peradeniya (2018–2019) and a Lecturer at IVA Para Medical Campus, Kandy (2018) πŸ§ͺ. She is registered with the Sri Lanka Medical Council (Reg. No. 2478) 🧾. Her hands-on academic guidance and innovative methodologies help bridge theoretical learning with practical healthcare applications. Dr. Fernando’s commitment to education and mentorship has left a positive impact on future generations of medical laboratory professionals.

Awards and Honors

Dr. Buddhi Fernando’s excellence in research and academia has earned her several prestigious accolades 🌟. In 2012, she was awarded a scholarship for the Global Health Student Exchange Program at Niigata University, Japan, recognizing her early promise in global public health πŸŒπŸ‡―πŸ‡΅. In 2017, she won First Place for the Best Oral Presentation at the Research Sessions of the Kandy Society of Medicine πŸ₯‡πŸŽ€, showcasing her talent in communicating scientific breakthroughs effectively. Her outstanding scholarly output is reflected in numerous publications across high-impact journals such as PLoS ONE, Kidney International Reports, and Environmental Geochemistry and Health πŸ“‘πŸ“ˆ. As a unit coordinator and mentor, her academic leadership has also been instrumental in enhancing research culture among peers and students πŸ§‘β€πŸŽ“πŸ”¬. These honors exemplify her capability to contribute significantly to science, education, and community health β€” making her a strong contender for the Best Researcher Award πŸ…πŸ“šπŸ§ͺ.

Research Focus

Dr. Buddhi Fernando’s research primarily centers on Chronic Kidney Disease of uncertain etiology (CKDu)β€”a pressing health crisis in Sri Lanka’s rural communities 🏞️🩺. Her Ph.D. work focused on identifying biomarker templates for CKDu and evaluating their utility for early detection, population screening, diagnosis, staging, and predicting complications πŸ§¬πŸ’‰. Her multidisciplinary approach integrates biochemical profiling, environmental toxicology, and molecular diagnostics to uncover the complex pathophysiology of CKDu. Beyond CKDu, she also explores diabetes-related cardiac effects and trace element imbalances βš–οΈβ€οΈ. Dr. Fernando’s work has high translational value, aiming to bridge the gap between laboratory science and community health solutions πŸ§ͺ🀝. Her collaborations with nephrologists, toxicologists, and global health experts reflect her broad academic network and research adaptability 🌐. Her contributions are vital to designing affordable, effective diagnostics for low-resource settings β€” making her research both locally relevant and globally significant πŸŒŽπŸ“ŠπŸ§ .

Publication Top Notes

Serum and urine fluoride levels in populations of high environmental fluoride exposure with endemic CKDu: a case–control study from Sri Lanka

 

Andrei Kozlov | Evolutionary Biology | Best Researcher Award

Andrei Kozlov | Evolutionary Biology | Best Researcher Award

Prof Andrei Kozlov, Vavilov Institute of General Genetics RAS, Russia

Prof. Andrei Kozlov is the Chief of the Lab of Gene Neofunctionalization at the Vavilov Institute of General Genetics RAS and the Director of The Biomedical Center in St. Petersburg, Russia. He also heads the Kozlov Laboratory of Theoretical Biology at Peter the Great St. Petersburg Polytechnic University. Born on May 22, 1950, in St. Petersburg, he earned his M.Sci. in Biochemistry from Leningrad State University and his Ph.D. from the Petrov Research Institute of Oncology. With extensive research in molecular virology and oncology, he has significantly contributed to HIV and cancer research. Prof. Kozlov is married with three children. πŸ“šπŸ”¬πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦

Publication profile

scopus

Education

In 1972, I earned my M.Sci. in Biochemistry from the Chair of Biochemistry at Leningrad State University, Leningrad, Russia. 🧬 From 1972 to 1975, I pursued my Ph.D. at the Petrov Research Institute of Oncology in St. Petersburg, Russia, focusing on the biochemistry of nucleic acids in both normal and malignant tissues. My Ph.D. thesis was titled β€œA comparative study of low molecular weight nuclear RNAs in normal and tumor tissues.” πŸ“š Between 1978 and 1979, I underwent postdoctoral research training in the Lab of Tumor Cell Biology under Dr. R. C. Gallo at the NCI, NIH, Bethesda, MD, USA, specializing in molecular oncovirology. πŸ”¬

Experience

In 1981, I began my career as a Molecular Biology Lecturer at the prestigious Boarding School β„–45 for especially talented children, attached to St. Petersburg State University. From 1983 to 1987, I lectured on the Biochemistry of nucleic acids at the university’s Department of Biochemistry. I founded and served as Deputy Director of the MPH Program at St. Petersburg State University from 2005 to 2012, where I also lectured on HIV/AIDS Epidemiology & Prevention. Since 2012, I’ve been the Founder and Chief of the St. Petersburg Seminar on Molecular and Evolutionary Biology. Between 2018 and 2019, I was a Professor in the Department of Medical Physics at Peter the Great St. Petersburg Polytechnic University, and since 2019, I have served as a High School Professor at the Institute of Biomedical Systems and Biotechnology. πŸŒŸπŸ“š

Honors

From 1992 to 2010, a Fellowship at the International Agency for Research on Cancer (IARC) was the foundation for many notable achievements. During this time, the annual international conference β€œAIDS, Cancer and Public Health” was established, and 19 conferences were chaired. Notable positions included advisory roles to the Russian parliament on HIV legislation (1994-1995), coordination of the Russian HIV Vaccine Project (1998-2002), and serving on various advisory boards. Numerous awards were received, such as the Russian National Chumakov Award (1999) and the Vernadsky Award (2005). The Vavilov Prize (2020) recognized contributions to cancer and HIV research. πŸ§¬πŸ…πŸŒ

Research focus

It seems you’re interested in the research focus of A.P. Kozlov. Based on the list of publications provided, Kozlov’s research primarily revolves around the evolutionary and developmental biology (evo-devo) of gene expression, the role of tumors in evolution, and the relationship between normal and tumor-like organs. Kozlov’s work integrates aspects of molecular evolution, gene expression patterns in cancer, and the emergence of novel cell types during evolution. Notably, Kozlov explores the theory of “carcino-evo-devo,” which posits a significant evolutionary role for hereditary tumors. This interdisciplinary approach spans genomics, oncology, and evolutionary biology, shedding light on the complexity of developmental processes and cancer evolution. πŸ§¬πŸ”¬πŸ¦ πŸ“Š

Publication top notes

Diagrams Describing the Evolution of Gene Expression, the Emergence of Novel Cell Types During Evolution, and Evo-devo

Carcino-Evo-Devo, A Theory of the Evolutionary Role of Hereditary Tumors

The Theory of Carcino-Evo-Devo and Its Non-Trivial Predictions

Mammalian tumor-like organs. 2. Mammalian adipose has many tumor features and obesity is a tumor-like process

Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development

Biological Computation and Compatibility Search in the Possibility Space as the Mechanism of Complexity Increase During Progressive Evolution

Erratum: Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans (Infectious Agents and Cancer (2019) 14 (46) DOI: 10.1186/s13027-019-0262-5)

Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans

Oncogenes, tumor suppressor and differentiation genes represent the oldest human gene classes and evolve concurrently

The increase of the magnitude of spontaneous viral blips in some participants of phase II clinical trial of therapeutic optimized HIV DNA vaccine candidate